These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3524660)

  • 1. Evolution of the myelodysplastic syndromes.
    Tricot G; Mecucci C; Van den Berghe H
    Br J Haematol; 1986 Aug; 63(4):609-14. PubMed ID: 3524660
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell origin of human myeloid blood cell neoplasms.
    Fialkow PJ
    Verh Dtsch Ges Pathol; 1990; 74():43-7. PubMed ID: 1708632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 4. Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia.
    Handa H; Nishimoto N; Inoue M; Yokohama A; Tsukamoto N; Saitoh T; Murakami H
    Hematol Oncol; 2019 Oct; 37(4):520-522. PubMed ID: 30990910
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.
    Layton DM; Mufti GJ
    Blut; 1986 Dec; 53(6):423-36. PubMed ID: 3542084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects].
    Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Brusamolino E; Bernasconi P; Inverardi D
    Haematologica; 1989 Oct; 74(5 Suppl):110-27. PubMed ID: 2512202
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia.
    San Miguel JF; González M; Cañizo MC; Anta JP; Hernández J; Ortega F; Borrasca L
    Blut; 1986 Jun; 52(6):357-63. PubMed ID: 3459562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.
    Eridani S; Chan LC; Halil O; Pearson TC
    Br J Haematol; 1985 Nov; 61(3):525-9. PubMed ID: 3864486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant multilobated mastocytes(promastocytes) in the setting of a refractory acute myeloid leukemia with myelodysplasia-related changes and monosomal karyotype.
    Ortuño FJ; Florensa L
    Blood; 2014 Feb; 123(9):1292. PubMed ID: 24716233
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute myeloid leukemia with myelodysplasia-related changes demonstrating prominent basophilic differentiation.
    Bahmanyar M; Chang H
    Blood; 2016 May; 127(20):2503. PubMed ID: 28092887
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndromes (preleukemia).
    Koeffler HP
    Semin Hematol; 1986 Oct; 23(4):284-99. PubMed ID: 3535083
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
    Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
    Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
    Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
    Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1509-27. PubMed ID: 3551435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis].
    Weryńska B
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myeloid leukemia with myelodysplasia-related changes showing basophilic differentiation.
    Wells R; Williams B; Bain BJ
    Am J Hematol; 2014 Nov; 89(11):1082. PubMed ID: 24941894
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia.
    Ali A; Penneroux J; Dal Bello R; Massé A; Quentin S; Unnikrishnan A; Hernandez L; Raffoux E; Ben Abdelali R; Renneville A; Preudhomme C; Pimanda J; Dombret H; Soulier J; Fenaux P; Clappier E; Adès L; Puissant A; Itzykson R
    Leukemia; 2018 Aug; 32(8):1856-1860. PubMed ID: 29535430
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelodysplastic relapse of de-novo AML: a heterogeneous entity?
    Layton DM; Ireland RM; Mufti GJ; Bellingham AJ
    Leuk Res; 1987; 11(11):1055-6. PubMed ID: 3480398
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in the myelodysplastic syndromes: a review.
    Tricot G; Vlietinck R; Verwilghen RL
    Scand J Haematol Suppl; 1986; 45():107-13. PubMed ID: 3515514
    [No Abstract]   [Full Text] [Related]  

  • 20. The monocytic component in myelodysplastic syndromes.
    Castoldi G; Rigolin GM
    Cancer Treat Res; 2001; 108():81-92. PubMed ID: 11702607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.